www.fdanews.com/articles/179774-anika-therapeutics-scores-ce-mark-for-tendon-injury-treatment
Anika Therapeutics Scores CE Mark for Tendon-Injury Treatment
December 20, 2016
Bedford, Massachusetts-based Anika Therapeutics, Inc. has won CE Mark for its Orthovisc-T, indicated to relieve pain and restore function of tendons damaged by chronic injury and overuse.
Orthovisc-T is designed to provide lubrication and encourage tendon gliding. It is administered via injection into the site of injury.
Orthovisc-T is the latest addition to Anika Therapeutics’ product portfolio. — Cynthia Jessup